Abstract
Over the past 12 months, the global cord blood banking industry has expanded
through double digit growth, due to new entrants in the cord blood banking
industry as well as revenue growth at existing operations. Deeper analysis
reveals that of existing cord blood banks, most fall into one of two
“camps,” either experiencing flat-line growth (less than 3% per
annum) or substantively building revenue (17% or more per annum).
This finding begs the questions:
- What factors are causing a substantial number of new cord blood banks to
open up business? Is it the result of a profit opportunity, an effect of
advances in therapeutic applications, a social response to more parents being
aware of the opportunity to store cord stem cells at birth, or are other
factors driving the activity?
- What will be the effect of these new entrants to the cord blood banking
industry for existing competitors?
- Perhaps most critically, what are the differences among the cord blood
banks that are experiencing flat-line growth, versus those that have
substantively built revenue over the past 12 months?
Additionally, quantitative analysis reveals that cord blood industry growth
has been particularly strong within the United Kingdom relative to other
regions over the trailing 12 months. This trend is expected to continue for a
period of 2-3 years, due to unique regulatory and competitive forces operating
in the region.
This top-selling report includes detailed analysis of factors that have
produced global double-digit industry growth over the past year and provides
guidance on how to break through flat-line growth to become a fast-growing
competitor. In addition, as a UK-specific version of the report, it analyzes
metrics specific to cord blood industry expansion within the United Kingdom.
Furthermore, the report includes detailed company profiles for all private
cord blood banks operating within the United Kingdom, including:
- 1. Cells4Life Ltd. UK
- 2. Cells Limited (a Cryo-Save brand)
- 3. Life Cells (previously CryoGenesis International Ltd.)
- 4. Future Health Technologies Ltd.
- 5. Smart Cells International
- 6. UK Cord Blood Bank Ltd.
- 7. BioVault Ltd.
- 8. Virgin Health Bank
- 9. UK Health Solutions Limited (closed operations in 2010)
Finally, a survey of 1,200 expectant parents is used to provide a roadmap for
how cord blood banks can best communicate and market their services to
potential clients. The findings presented in this report reveal specific
reasons that parents elect to store cord blood and what factors influence
their decision-making in choosing a specific bank.
Target Audience of Report:
The report will greatly enhance the ability of both public and private cord
blood banks to make competitive decisions within the UK cord blood banking
environment.
In addition, cord blood companies in surrounding geographic regions may find
the UK model of growth presented here to be interesting and pertinent to their
own business decisions.
Cord blood companies operating in other global regions that plan to establish
a local UK branch will benefit from understanding the regional market dynamics
presented within the report.
Research product companies that produce cord blood stem cell products, such as
Bio E, Stem Cell Technologies, and AllCells, will also find utility in the
findings.
Biotechnology companies that produce equipment for the cord blood banking
industry, such as cryo-bags, freezers, and cell culture materials will be
interested in the report for purposes of understanding industry growth
dynamics and analyzing the financial state of companies profiled within it.
Organizations entering into long-term collaborative studies with UK cord blood
banks will consider the content valuable, as will companies with potential
interest in company acquisition in the region. (This has been common in other
regions, with Perkin Elmer acquiring ViaCord, HealthBank Biotech acquiring
Pacificord, etc.)
Private investment firms that invest in high-technology sectors, government
entities that oversee regulation of the cord blood industry, and public health
institutions that collect cord blood units may also be interested in the
report' s findings.
Report Title: Capitalizing on Opportunities in Cord Blood Industry Growth - UK
Specific Version, with Detailed Company Profiles
Report Statistics
- Number of Pages: 228
- Publication Date: September 2010
Table of Contents
PART 1: TRAILING 12 MONTH ANALYSIS
I. Rate of Entrants to the Cord Blood Banking Industry
- A. Limiting Factors
- 1. Accreditations
- 2. Security
- 3. Laboratory & Storage Requirements
- B. 12 Month Trends
- 1. Trailing Twelve Month (TTM) Growth Rates
- 2. Revenue Breakdown by Market Component
- 3. Critical Analysis of Trends
II. Bimodal Distribution of Revenue Growth among Global Cord Blood Banks
- A. Flat-Line Growth Companies (< 3% per Year)
- B. Substantive Revenue Growth Companies (17% or More Per Year)
III. Effect of New Entrants for Existing Competitors
PART 2: CORD BLOOD BANKING, INDUSTRY OVERVIEW
I. Summary of Conditions
II. Background
- A. Fetal Cord Blood Characteristics
- B. Existing Treatments
- C. Future Applications
III. Cord Blood Banking Industry
- A. History
- B. Private vs. Public Cord Blood Banks
- 1. UK Private Banks
- a. Overview
- b. Number of Private Banks
- 2. UK Public Banking
- 3. International Banks
- a. Overview
- b. Number Private Cord Blood Banks by International Region
IV. Market Characterization
- A. Detailed Company Profiles for Private UK Cord Blood Banks
- 1. Cells4Life Ltd. UK
- 2. Cells Limited (a Cryo-Save brand)
- 3. Life Cells (previously CryoGenesis International Ltd.)
- 4. Future Health Technologies Ltd.
- 5. Smart Cells International
- 6. UK Cord Blood Bank Ltd.
- 7. BioVault Ltd.
- 8. Virgin Health Bank
- 9. UK Health Solutions Limited (no longer operating)
- B. List of International Cord Blood Banks, by Geographic Region
- 1. U.S. Cord Blood Banks
- 2. Canadian Cord Blood Banks
- 3. Mexican Cord Blood Banks
- 4. South/Central American Cord Blood Banks
- 5. European Cord Blood Banks
- 6. Middle Eastern Cord Blood Banks
- 7. Indian Cord Blood Banks
- 8. Asian Cord Blood Banks
- 9. Australian / New Zealand Cord Blood Banks
- 10. African Cord Blood Banks
- C. List of International Public Cord Blood Banks (Alphabetical by
Country)
- D. Worldwide List of AABB Accredited Cord Blood Facilities
V. International Analysis - Trends, Policies and Industry Conditions (by Country)
- A. NORTH & SOUTH AMERICA
- 1. Canada
- 2. Mexico
- 3. United States
- 4. Brazil
- 5. Chile
- 6. Colombia
- B. ASIA
- 1. China
- 2. Japan
- 3. Korea
- 4. Malaysia
- 5. Taiwan
- 6. Singapore
- 7. Thailand
- C. INDIA
- D. AUSTRALIA & NEW ZEALAND
- E. EUROPE
- 1. European Union
- a. Policy Overview
- b. NETCORD Foundation
- 2. France
- 3. Germany & Austria
- 4. Italy
- 5. Netherlands
- 6. Spain
- 7. Poland
- 8. Russian Federation
- 9. United Kingdom
VI. Cost Analysis: Reasons for Variation in Cord Blood Pricing
- A. Companies have Flexibility in the Pricing that they Set
- B. Companies have Variables in the Services that they Offer
- C. Variable Fee Breakdowns
VII. Comparative Analysis of Quality Variables
- A. Technical Variables
- 1. Vapor-Phase Storage vs. Liquid-Phase Storage
- 2. Cryo-bags vs. Cryo-vials
- 3. Pentastarch vs. Hetastarch
- 4. Computer Controlled vs. Manual Rate Freezing
- 5. Whole Sample vs. Volume Reduction
- 6. High-Control vs. Low-Control Aseptic Processing
- B. Corporate Variables
- 1. Corporate Stability
- 2. Scientific Expertise
PART 3: EXPECTANT PARENTS, SURVEY RESULTS & FINDINGS
I. Survey Overview
- A. Survey Population
- B. Characterization of Market Survey Respondents
- 1. Geographic Distribution of Market Survey Respondents
- 2. Household Income Distribution of Survey Respondents
- 3. Respondent Breakdown by Race
- 4. Respondent Breakdown by Gender
- 5. Respondent Breakdown by Level of Education
- 6. Respondent Breakdown by Location (City vs. Suburban vs. Rural)
- 7. Regional Breakdown of U.S. Respondents
- 8. Demographic Conclusions
II. Rates of Awareness: Unaware / Minimally Informed / Moderately Informed / Knowledgeable
- A. Overall
- B. By Gender
- C. By Household Income
- D. By Education
- E. By Race
- F. By Geographic Location (City vs. Suburban vs. Rural)
- G. By Number of Existing Children within Family (e.g. Birth Order)
III. Factors Influencing Awareness
- A. Personal Exposure: Relative Impact of Family, Co-Workers, Peers
- B. Informational Sources: Information Sites, Books Medical
Pamphlets, Government Sources
- C. Medical Exposure: General Doctors, Ob / Gyn, Midwifes, Nurse,
Other
- D. Promotional Sources: Internet Advertisements, Print
Advertisements, Radio, TV, Other
IV. Factors Influencing Parental Decision-Making
- A. Factors Influencing the Decision Not to Store Cord Blood
- 1. Knowledge Level
- 2. Price Sensitivity
- 3. Safety Concerns
- 4. Lack of Access
- 5. Misconceptions
- B. Factors Influencing the Decision for Private vs. Public Storage
of Cord Blood
- 1. Ethical Beliefs
- 2. Gender
- 3. Total Household Income
- 4. Level of Education (Highest Level Achieved by at Least One Parent)
- 5. Race
- 6. Geographic Location
- 7. Access to Reliable Healthcare
- 8. Number of Existing Children within Family (Birth Order)
- 9. Source of Knowledge
- 10. Perceived Support of Medical Staff
- 11. Family Medical History
- C. International Analysis of Cord Blood Banking Perceptions
(Region-by-Region)
V. Parental Responsiveness to Health Statistics
- A. Overview
- B. Health Statistics
- C. Health Statistic Conclusions
VI. Parental Expectations
- A. Quality of Services
- B. Willingness to Educate/Inform
- C. Reputability of Organization
VII. Informative Websites: Online Sources Utilized by Expectant Parents
- A. Overview of Websites
- 1. Information Only
- 2. Commercial Affiliation
- B. Dominant Regional Websites (International Analysis)
- C. Most Important Criteria Used to Identify Sites to Inform
Decision-Making
- D. Underlying Reasons for Visiting Online Resources
VIII. Trends
- A. Rates of Cord Blood Storage (units per year)
- B. Rates of Parental Awareness
- C. Cord Blood Research Publication Rates
- D. Cord Blood Research Funding Levels
- E. Cord Blood Patent Breakdown
- F. Rates of Cord Blood Research Product Development
IX. Private Cord Blood Banking: The “Model Customer”
- A. Traits of a “Model Customer”
- 1. “Model Customer” for a Private Cord Blood Bank
- 2. “Model Customer” for a Public Cord Blood Bank
- B. Ideal Price Range
- C. Approaches for Communicating with Expectant Parents
